CRL
Charles River Laboratories International, Inc. · Healthcare
EVP, Corp Strategy, Develop Joseph W Laplume sold $355K of Charles River Laboratories International, Inc.
Sold$354,861
$199.36Price
1,780Shares
−7%Stake
What CRL did after the filing
- The stock from Mon, Aug 12 close, $194.31
- +3.2%
- S&P 500, same days
- +7.5%
Measured over 30 trading days, to the Sep 24 close.
Traded Thu, Aug 8. Filed Mon, Aug 12, 12:13 PM ET, during the session. Returns use the Aug 12 close and the Sep 24 close. Not investment advice.